Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 4

The renaissance of fixed dose combinations: Combivir

Authors Simon D Portsmouth, Christopher J Scott

Published 15 September 2007 Volume 2007:3(4) Pages 579—583

Simon D Portsmouth1, Christopher J Scott 2

1St Mary’s Hospital, London, UK; 2Chelsea & Westminster Hospital, London, UK

Abstract: Combivir is a fixed dose combination tablet of two antiretroviral drugs; zidovudine and lamivudine, used in the treatment of HIV-1 infection. AZT was the first antiretroviral used in clinical trials and the addition of lamivudine improved its effectiveness. With the introduction of highly active antiretroviral therapy in the form of a combination of three drugs including two nucleoside analogues, Combivir became the gold standard nucleoside ‘backbone’ until very recently. Combivir was the first combination agent and simplified HIV therapy greatly. The introduction of newer fixed dose combinations with the advantage of once daily dosing and improved tolerability and toxicity profiles has made Combivir a less popular choice in treatment naïve individuals needing to start therapy.

Keywords: Combivir, zidovudine, lamivudine, antiretroviral, HAART, HIV

Download Article [PDF] 

Readers of this article also read:

Synthesis, characterization, and immune efficacy of layered double hydroxide@SiO2 nanoparticles with shell-core structure as a delivery carrier for Newcastle disease virus DNA vaccine

Zhao K, Rong G, Guo C, Luo X, Kang H, Sun Y, Dai C, Wang X, Wang X, Jin Z, Cui S, Sun Q

International Journal of Nanomedicine 2015, 10:2895-2911

Published Date: 13 April 2015

Sequential release of salidroside and paeonol from a nanosphere-hydrogel system inhibits ultraviolet B-induced melanogenesis in guinea pig skin

Peng LH, Xu SY, Shan YH, Wei W, Liu S, Zhang CZ, Wu JH, Liang WQ, Gao JQ

International Journal of Nanomedicine 2014, 9:1897-1908

Published Date: 16 April 2014

Higher lung deposition with Respimat® Soft Mist™ Inhaler than HFA-MDI in COPD patients with poor technique

Peter Brand, Bettina Hederer, George Austen, Helen Dewberry, Thomas Meyer

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:763-770

Published Date: 5 December 2008

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis

Vincenzo Savica, Domenico Santoro, Paolo Monardo, Agostino Mallamace, Guido Bellinghieri

Therapeutics and Clinical Risk Management 2008, 4:821-826

Published Date: 8 August 2008

Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria

Elmir Omerovic, Gerhard Brohall, Markus Müller, Truls Råmunddal, Göran Matejka, et al

Therapeutics and Clinical Risk Management 2008, 4:705-711

Published Date: 8 August 2008

Formoterol in the management of chronic obstructive pulmonary disease

Paschalis Steiropoulos, Argyris Tzouvelekis, Demosthenes Bouros

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:205-215

Published Date: 6 June 2008

Developments in the management of autosomal dominant polycystic kidney disease

Amirali Masoumi, Berenice Reed-Gitomer, Catherine Kelleher, Mir Reza Bekheirnia, Robert W Schrier

Therapeutics and Clinical Risk Management 2008, 4:393-407

Published Date: 11 April 2008

Moderate and severe plaque psoriasis: cost-of-illness study in Italy

GL Colombo, GF Altomare, K Peris, P Martini, G Quarta

Therapeutics and Clinical Risk Management 2008, 4:559-568

Published Date: 11 April 2008

Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease

Chiara Bellia, Giulia Bivona, Concetta Scazzone, Marcello Ciaccio

Therapeutics and Clinical Risk Management 2007, 3:999-1001

Published Date: 15 January 2008

Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results

Marco Metra, Savina Nodari, Tania Bordonali, Patrizia Milani, Carlo Lombardi, et al

Therapeutics and Clinical Risk Management 2007, 3:569-578

Published Date: 15 September 2007